Press release
Gastrointestinal Over the Counter (OTC) Drugs Segmental Analysis by Therapeutics, Diagnostics, Patient, Drugs Policy and Regulatory Landscape
Gastrointestinal diseases involve the gastrointestinal tract including stomach, esophagus, large intestine, small intestine, gallbladder, rectum, liver and pancreas. Over the counter (OTC) drugs are medications that are available without any prescription from the doctor. Over the counter drugs are chosen by regulatory agencies very carefully so as to ensure their efficacy and safety.
Request to Get the Sample Pages at:
https://www.psmarketresearch.com/market-analysis/gastrointestinal-otc-drugs-market/report-sample
The gastrointestinal over the counter drugs can also be bought without any prescription of doctor. The gastrointestinal over the counter drugs are used for indications such as vomiting, gastro esophageal reflux disease (GERD), diarrhea, flatulence and constipation. The over the counter drugs are not compelled by regulatory guidelines, but they need to fulfill the drug monograph of a certain country.
Access Detailed Report Summary:
https://www.psmarketresearch.com/market-analysis/gastrointestinal-otc-drugs-market
On the basis of types of product, the gastrointestinal over the counter drugs market can be categorized as laxatives, gastrointestinal cancer treatments, gastric acid reducers, anti diarrheals, proton pump inhibitors, h2 inhibitors, gastric acid neutralizers, bowel anti-inflammatory and anti emetics. On the basis of indication, the gastrointestinal over the counter drugs market can be categorized as nausea due to motion sickness, heartburn, flatulence, diarrhea and constipation.
High expenditure on advertisement is one of the major factors restraining the growth of the gastrointestinal over the counter drugs market.
Many countries have applied regulations regarding the gastrointestinal over the counter drugs in their countries. In Canada, an intermediate category exist which states that non prescription stuffs must be kept in a store room, behind the counter, or on a shelf visible to the pharmacist and the stuffs include weak muscle relaxants, codeine products, and antihistamines. In the Netherlands, categories of non prescription drugs have been made as uitsluitend recept, uitsluitend apotheek, uitsluitend apotheek of drogist and algemene verkoop. The uitsluitend apotheek drug can be on the shelves like any other product. Uitsluitend apotheek of drogist can be sold at drugstores and it includes only a small selection of drugs such as cough medicine and painkillers. Algemene verkoop drugs can be sold at gas stations and supermarkets, and it includes drugs with minimal risk to the public such as cetirizine, paracetamol, loperamide, and 200 mg ibuprofen.
Some of the competitors in the gastrointestinal over the counter drugs market are Procter & Gamble, GlaxoSmithKline Pharmaceuticals Limited, Purdue Pharma L.P., Bayer AG, Boehringer Ingelheim GmbH, Johnson & Johnson Private Limited, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Reckitt Benckiser Group plc, C.B. Fleet Company, Inc., Perrigo Company plc, Sanofi, OMEGA SA, Abbott Laboratories, and Nestle SA.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastrointestinal Over the Counter (OTC) Drugs Segmental Analysis by Therapeutics, Diagnostics, Patient, Drugs Policy and Regulatory Landscape here
News-ID: 1945788 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for Gastrointestinal
Prominent Gastrointestinal Pathogen Testing Market Trend for 2025: Advancements …
What combination of drivers is leading to accelerated growth in the gastrointestinal pathogen testing market?
The rise in foodborne diseases is expected to drive the growth of the gastrointestinal pathogen testing market. Foodborne diseases, caused by consuming contaminated food or drinks, are on the rise due to changes in food production and distribution, inadequate food safety measures, and climate change. Gastrointestinal pathogen testing helps identify pathogens responsible for foodborne illnesses, aiding…
Major Market Shift in Gastrointestinal Pathogen Testing Industry: Advancements I …
What Is the Forecasted Market Size and Growth Rate for the Gastrointestinal Pathogen Testing Market?
The market size for gastrointestinal pathogen testing has seen a consistent growth lately. Projected to surge from $4.05 billion in 2024 to $4.24 billion in 2025, it is expected to grow at a compound annual growth rate (CAGR) of 4.6%. The growth observed during the historic period can be ascribed to factors such as the amplified…
Gastrointestinal Bleeding Treatment Devices Market Report 2024 - Gastrointestina …
"The Business Research Company recently released a comprehensive report on the Global Gastrointestinal Bleeding Treatment Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
Gastrointestinal (GI) Stents Market is Driven by Rising Prevalence of Gastroint …
The Gastrointestinal (GI) Stents Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well.
View Report - https://www.theinsightpartners.com/reports/gastrointestinal-gi-stents-market/
Gastrointestinal stents are used as an effective alternate to perform…
Gastrointestinal Devices Market Report 2018: Segmentation by Type (Gastrointesti …
Global Gastrointestinal Devices market research report provides company profile for Coloplast, Given Imaging, CONMED, Covidien, Ethicon, Olympus, Boston Scientific and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation…
Global Gastrointestinal Industry Report 2016
Global Gastrointestinal Industry 2016 Market Overview, Size, Share, Trends, Analysis, Technology, Applications, Growth, Market Status, Demands, Insights, Development, Research and Forecast 2016-2020.
The analysts of the global Gastrointestinal market report have taken on the challenge of procuring insightful data from reliable resources and precisely segregating critical market dynamics, given the voluminous amount of information available. Established and novice players in the Gastrointestinal market can secure their position on the cutting edge…
